Revagenix, Inc.
Andrew McCandlish is an experienced Chief Operating Officer and Founder/Principal in the biotechnology and pharmaceutical industry. With a strong background in business development, corporate development, and strategic planning, Andrew has worked with various companies in roles such as Head of US Business Development, Vice President of Business Development, and Director of Corporate Development. Their expertise also extends to areas like non-dilutive funding, alliance management, and product development. Andrew holds a PhD in Molecular Biology from Princeton University and a BS with Honors in Molecular Genetics and Business Marketing from The Ohio State University.
This person is not in any teams